India is at a historic turning point in the insulin pen market. With the expiration of the semaglutide patent in March 2026 and Novo Nordisk's gradual withdrawal from the Indian insulin pen market, a market worth 60-80 billion rupees is opening up to Indian pharmaceutical companies. Meanwhile, global demand for insulin pens is projected to reach 500 million units annually over the next 2-3 years, and surge to 2 billion units by 2030-32.
In this supply-side race, Xinfuda, with over 20 years of experience in pharmaceutical packaging exports and its accumulated expertise in insulin pen R&D, aims to become the ideal partner for Indian biopharmaceutical companies to capitalize on this historic opportunity.
From Packaging to Injection Pens: Unique Advantages of Industry Extension
For over 20 years, Xinfuda has provided high-quality pharmaceutical packaging to global pharmaceutical companies, possessing a deep understanding of drug container requirements. This unique background gives us unparalleled advantages. We are not novices starting from scratch in the injection pen industry, but rather cross-disciplinary experts with a profound understanding of pharmaceuticals.
1.A complete product line covering diverse needs
Disposable Injection Pens: Insulin, GLP-1, Growth Hormone
Reusable Injection Pens: Long-term treatment, economical and environmentally friendly
Internal Rotation Driven Injection Pens: High-viscosity biologics
Customized Injection Pens: Developed specifically for your drug's characteristics
Your Benefits: No matter what stage your drug is in or what type of injection pen you need, Xinfuda has a matching solution.
2.Internal rotation drive technology solves the problem of high-viscosity drug delivery.
Traditional injection pens require significant effort to inject high-viscosity biologics (such as GLP-1 and monoclonal antibodies), resulting in a poor patient experience. Xinfuda's independently developed internal rotation drive technology:
Reduces injection force by 60% (only 3-5N)
Provides stable force throughout the injection, with no peak resistance
Especially suitable for elderly patients and patients with limited hand strength
Your benefits: Even with highly viscous medications, patients can easily complete the injection, improving treatment adherence.
3.OEM/ODM Core Customization Capabilities
Appearance Customization
Brand Logo Laser Engraving
Exclusive Color Scheme (Supports Pantone Color Codes)
Personalized Packaging Box Design
Function Customization
Dosage Range (0-30/60/80/100 Units)
Minimum Increment (0.5 Unit / 1 Unit)
Operating Force Adjustment (3-8N Adjustable)
Feedback Methods (Click Sound Loudness, Touch Intensity)
Structure Customization
Compatibility Optimization with Specific Drugs
Special Population Adaptation (Children, Elderly, Visually Impaired)
Anti-misoperation Design
Diversified Business Layout, Supported by Comprehensive Strength
Xinfuda Group has four major business segments: injection pens, medical aesthetic products, cosmetics, and medical devices. This diversified layout brings:
Stronger supply chain integration capabilities
More extensive experience in material application
A more robust foundation for business operations
Your Benefits: Partnering with a company with comprehensive strength ensures a long-term, stable partnership.
Copyright © Shijiazhuang Xinfuda Medical Packaging Co., Ltd. All Rights
MAKE AN ENQUIRY
